Preclinical studies in a myasthenia gravis model with circulating anti-MuSK autoantibodies have shown that MuSK-CAAR T cells can reduce anti-MuSK antibody titers without inducing widespread B cell depletion (133). The gene discussed is MUSK; the disease is myasthenia gravis.